Scarica l'app Stockscreener
9.53
1.45%
-0.14
Dopo l'orario di chiusura:
9.53
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-05-31 | 2025-02-28 | 2024-08-31 | 2024-05-31 | 2024-02-29 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
138.75%
44.06
|
18.45 | 12.59 | 12.09 | 16.59 |
Operating Expenses
|
13.60%
92.38
|
81.32 | 67.20 | 60.63 | 61.80 |
| Benefits Costs and Expenses |
15.98%
86.76
|
74.80 | 61.46 | 56.55 | 58.01 |
| Costs And Expenses |
15.98%
86.76
|
74.80 | 61.46 | 56.55 | 58.01 |
| Depreciation and Amortization |
4.60%
2.242
|
2.35 | 2.394 | 2.33 | 2.045 |
| Operating Income/Loss |
23.13%
-48.32
|
-62.86 | -54.61 | -48.54 | -45.22 |
| Income/Loss From Continuing Operations Before Tax |
24.22%
-42.70
|
-56.35 | -48.87 | -44.46 | -41.43 |
| Income Tax Expense/Benefit |
0.76
|
- | 0.082 | 0.09 | 0.09 |
| Income/Loss From Continuing Operations After Tax |
22.87%
-43.46
|
-56.35 | -48.96 | -44.55 | -41.52 |
|
Net Income/Loss
|
22.87%
-43.46
|
-56.35 | -48.96 | -44.55 | -41.52 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.38%
83.88
|
83.56 | 72.78 | 62.38 | 54.90 |
| Diluted Average Shares |
0.38%
83.88
|
83.56 | 72.78 | 62.38 | 54.90 |
| Basic Earnings Per Share |
22.39%
-0.52
|
-0.67 | -0.67 | -0.71 | -0.76 |
| Diluted Earnings Per Share |
22.39%
-0.52
|
-0.67 | -0.67 | -0.71 | -0.76 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):